Alopecia

Posts

Alopecia Treatment Market

Global Alopecia Market Insights

Global Alopecia Market Insights and Forecast to 2026

Alopecia market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alopecia market will be able to gain the upper hand as they use the report as a powerful resource.

The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Alopecia market is segmented into

Oral treatment
Topical treatment
Other treatment

Segment by Application, the Alopecia market is segmented into

Male
Female

Regional and Country-level Analysis

The Alopecia market is analysed and market size information is provided by regions (countries).

The key regions covered in the Alopecia market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes a country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Alopecia Market Share Analysis

Alopecia market competitive landscape provides details and data information by players. The report offers a comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020.

It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Alopecia business, the date to enter into the Alopecia market, Alopecia product introduction, recent developments, etc.

The major vendors covered:

Lifes2good
Kirkland Signature
Johnson & Johnson
Dr Reddys Laboratories.
Cipla.
Alpecin.
Vitabiotics.
Sun Pharma.
Phyto Ales Group

Global Alopecia Market Insights and Forecast to 2026

Source

Previous Posts

Alopecia Treatment Market

Global Alopecia Market Insights

Global Alopecia Market Insights and Forecast to 2026

Alopecia market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alopecia market will be able to gain the upper hand as they use the report as a powerful resource.

The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Alopecia market is segmented into

Oral treatment
Topical treatment
Other treatment

Segment by Application, the Alopecia market is segmented into

Male
Female

Regional and Country-level Analysis

The Alopecia market is analysed and market size information is provided by regions (countries).

The key regions covered in the Alopecia market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes a country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Alopecia Market Share Analysis

Alopecia market competitive landscape provides details and data information by players. The report offers a comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020.

It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Alopecia business, the date to enter into the Alopecia market, Alopecia product introduction, recent developments, etc.

The major vendors covered:

Lifes2good
Kirkland Signature
Johnson & Johnson
Dr Reddys Laboratories.
Cipla.
Alpecin.
Vitabiotics.
Sun Pharma.
Phyto Ales Group

Global Alopecia Market Insights and Forecast to 2026

Source

Previous Posts

Alopecia Treatment Market

Androgenic Alopecia Global Clinical Trials

Androgenic Alopecia Global Clinical Trials Review, H1, 2020

Summary

The clinical trial report, “Androgenic Alopecia Global Clinical Trials Review, H1, 2020″ provides an overview of Androgenic Alopecia Clinical trials scenario. This report provides top-line data relating to the clinical trials on Androgenic Alopecia.

The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.

The report also provides prominent drugs for in-progress trials (based on a number of ongoing trials). Clinical Trial Reports are generated using proprietary database – Pharma – Clinical trials database.

Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision-making capabilities and helps to create an effective counter-strategy to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape
– The report provides top-level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with a reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– The report provides the latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Androgenic Alopecia Global Clinical Trials Review, H1, 2020

Source

Previous Posts

Robotic Hair Transplant System Market

Robotic Hair Transplant System Market

Robotic Hair Transplant System Market Forecast, Trend Analysis & Competition Tracking – Global Review 2018 to 2028

Alopecia or hair loss is a chronic dermatology disease in which there is either partial or complete loss of hair from the scalp and other parts of the body.

According to the National Alopecia Areata Foundation, approximately 6.8 million people in the United States and 147 million worldwide have developed alopecia at some point in time.

A strong family history is one of the main reasons contributing towards pattern baldness or androgenic alopecia in both males and females. As estimated by the International Society of Hair Restoration Surgery (ISHRS), more than 35 million men in the U.S. currently suffer from male pattern baldness. ARTAS robotic hair transplant systems make the hair translation procedure more effective and less painful.

The ARTAS robotic hair transplant system is a computer-assisted equipment use to improve the quality of follicle. It also enhances the quality of the most challenging Follicle Extraction Unit (FUE). Various components of an ARTAS robotic hair transplant system are image-guided robotic arm, small dermal punches and a computer interface.

artas

The robot is guided by a 3-D imaging software and the cameras. The device removes the hair follicle at a rate of 1,000 per hour. The FUE procedure involves removing hair from the donor region of the scalp and then implanting it into the recipient site. The separation of the follicular units from the donor tissue is a tedious, repetitive and labour intensive process. The FUE process requires great precision to prevent damage to follicular units.

The ARTAS robotic hair transplant system has significantly increased the accuracy of the FUE procedure. The ARTAS robotic hair transplant system reduces harvesting time and minimizes any damage to hair follicles with its efficacy and great precision. The ARTAS robotic hair transplant system also improves the chances of graft survival. It is also far more comfortable than traditional and more invasive hair restoration processes.

Robotic Hair Transplant System Market: Drivers and Restraints

Increasing prevalence of various dermatological related disorders will drive the robotic hair transplant system market during the forecast period. Unhealthy lifestyle patterns and an increase in stress levels will further contribute towards the growth of hair restoration treatment and robotic hair transplant systems market.

Genetic and other environmental factors increase baldness among men and women. Technologically improved and minimally invasive transplant treatment methods will increase the growth of the robotic hair transplant system market during the forecast period.

High adoption among people of young age to enhance their appearance will further fuel the overall market of robotic hair transplant systems. However, high cost and various side effects associated with the treatment, such as the itchy scalp, hair thinning, etc., might hinder the growth of the robotic hair transplant system market during the forecast period.

Robotic Hair Transplant System Market: Segmentation

The robotic hair transplant system market can be segmented on the basis of end-user and region. Based on end-user, the hair transplant system market is segmented as:

  • Dermatology Clinics
  • Hospitals

Robotic Hair Transplant System Market: Overview

The ARTAS robotic hair transplant system market is growing at a fast pace as these systems are quite efficient and make the entire procedure more comfortable. Higher adoption of robotic hair transplant treatment over traditional, more time-consuming treatments has given a boost to the overall market of ARTAS robotic hair transplant system.

Robotic Hair Transplant System Market: Regional Outlook

Geographically, the global robotic hair transplant system market is segmented into North America, Latin America, Europe, CIS & Russia, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America dominates the robotic hair transplant system market due to the rapid technological advancements and better healthcare facilities.

It is followed by Europe because of high adoption among end-users. Asia-Pacific is expected to witness fast expansion in robotic hair transplant system market due to increasing prevalence of skin-related disorders and growth in healthcare infrastructure. Middle East and African regions will witness sluggish growth because of a lack of awareness among people and the high cost of the treatment.

Robotic Hair Transplant System Market: Key Players

Restoration robotics Inc. is the manufacturer of ARTAS robotic hair transplantation systems, which was FDA approved in 2011. Other manufacturers are also focusing on developing other robotic hair transplant systems.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America
    • US
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Chile
    • Peru
    • Rest of LATAM
  • Europe
    • EU – 4 (Germany, France, Italy, Spain)
    • UK
    • BENELUX (Belgium, Netherlands, Luxemburg)
    • NORDIC (Norway, Denmark, Iceland, Sweden)
    • Eastern Europe (Poland, Ukraine, Czech Rep. etc.)
    • Rest of Europe
  • CIS & Russia
  • Japan
  • APEJ
    • Greater China
    • India
    • Korea
    • ASEAN Countries
    • Rest of APEJ
  • Middle East & Africa
    • GCC Countries
    • Turkey
    • Iran
    • Israel
    • South Africa
  • Rest of MEA

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

Robotic Hair Transplant System Market Forecast, Trend Analysis & Competition Tracking – Global Review 2018 to 2028

Source

Previous Posts

Arena Starts Phase II Alopecia Areata Study on Etrasimod

Arena Starts Phase II Alopecia Areata Study on Etrasimod

Arena (ARNA) Starts Phase II Alopecia Areata Study on Etrasimod

Arena Pharmaceuticals, Inc. ARNA announced that it has dosed first patients in a phase II study to evaluate its key pipeline candidate — etrasimod — as a potential treatment for moderate-to-severe alopecia areata. The study will evaluate the 2mg dose of the candidate for efficacy and safety over 24 weeks.

The primary endpoint of the phase II study is the percent change in the Severity of Alopecia Tool (“SALT”) score from baseline. Data from the study is anticipated in 2021.

The candidate has demonstrated the potential to reduce inflammation and restore hair growth in earlier stage studies.

Shares of Arena have gained 50.5% year to date compared with the industry’s increase of 2.7%.

Alopecia areata is an autoimmune dermatologic condition that results in patchy non-scarring hair loss, usually affecting the scalp. There is no FDA approved drug presently available to treat this condition, which can lead to high levels of depression and anxiety in patients.

Pfizer PFE is another company developing an oral JAK3 inhibitor candidate, PF-06651600 for Alopecia areata in a pivotal study.

Apart from alopecia areata, Arena is developing etrasimod in other indications as well. The candidate is presently in late-stage development for ulcerative colitis (“UC”).

Arena is currently enrolling patients in two pivotal phase III studies — ELEVATE UC 52 and ELEVATE UC 12 — evaluating etrasimod for treating moderately-to-severely active UC.

A phase IIb study — ADVISE — is evaluating etrasimod in patients with atopic dermatitis (“AD”). Data from the study is expected later this year. Another phase IIb study — CULTIVATE — was initiated earlier this year to evaluate the candidate in Crohn’s disease. The company has plans to start a mid-stage study to evaluate the candidate for eosinophilic esophagitis, a gastro-intestinal disease by year-end.

Arena has another key pipeline candidate, olonarib. The phase II CAPTIVATE study is evaluating olaparib as a treatment for abdominal pain associated with irritable bowel syndrome. Data from the study is expected later this year.

We note that Arena is progressing well with its key pipeline candidates. However, the company will face stiff competition from multiple approved drugs in their targeted indications.

There are several drugs approved for treating UC including AbbVie’s ABBV multi-billion dollar drug, Humira. Sanofi/Regeneron’s REGN Dupixent is one of the top drugs approved for treating AD.

Moreover, olaparib, following potential approval, will compete with AbbVie/Ironwood Pharma’s Linzess.

Arena (ARNA) Starts Phase II Alopecia Areata Study on Etrasimod

Source

Previous Posts

Alopecia Treatment Market

Research on Alopecia Market

Research on Alopecia Market (impact of COVID-19) 2020-2026


In this study, we have issued the much-needed information on the Global Alopecia Market 2020 which covers detailed information about the Alopecia market size, Alopecia market trends, industrial dynamics and Alopecia market share.

Furthermore, it drops light on the series of instantly changing Alopecia market scenarios as well as the upcoming assessment of numerous factors that completely impacting the global Alopecia market report.

The research on the world Alopecia market illustrates the whole international market alongside a detailed analysis of the revenue growth and profitability of the Alopecia market.

The latest report on the worldwide Alopecia market represents a comprehensive understanding of the futuristic Alopecia market estimations, based on the historical and current predictions. It is considered to be the significant and professional document that especially focusing on the Alopecia market drivers, size, leading segments and topological zones.

Moreover, the report splits the global Alopecia market size by volume and value on the basis of product types, applications, well-established vendors and major geographies.

Pivotal industry players involved in this report are:

Lifes2good
Kirkland Signature
Johnson & Johnson
Dr Reddy’s Laboratories.
Cipla.
Alpecin.
Vitabiotics.
Sun Pharma.
Phyto Ales Group

The Global Alopecia market divided by product types:

Oral treatment
Topical treatment
Other treatment

Alopecia market segregation by application:

Male
Female

In the recent research document, we have listed out a wide range of business policies, mergers & acquisitions, collaborations, upcoming as well as trending innovative techniques. It also demonstrates systematic information and analysis related to the Global Alopecia market trends, growth factors, share, segments, challenges, opportunities and forecasts details from 2020 to 2026.

The global Alopecia market report showcases several factors that are driving the industrial growth and meanwhile, evaluates the present market scenario, insightful details and new updates about the corresponding segments involved in the Alopecia market report. It also sheds light on the price trends, demand and supply ratio, historical as well as forecasted industry data, and company shares of the top Alopecia market players by geography.

The report has been designed with the help of series of methodologies and essential techniques like SWOT analysis, Porter’s Five Forces analysis, graphical representation, pie charts and real-time analytics are helpful to add more precise and clear understanding about the Alopecia market-related facts and figures.

Research on Alopecia Market (impact of COVID-19) 2020-2026

Source

Previous Posts

Global Alopecia Treatment Industry Research Report

Alopecia Market

Alopecia Market

Market Summary

The Alopecia Market is expected to reach USD 12.99 Billion by 2026, according to a new report by Reports and Data. This can be mainly associated with the rising predominance of chronic disorders such as hyperthyroidism, hypothyroidism, acute stress disorder, lupus, and hypo pituitarism.

Moreover, increasing incidence of Hodgkin’s disease, Hashimoto’s disease, Addison’s disease, and celiac disease along with factors such as access to treatment quickly are expected to drive the market growth.

However, the high cost of treatment and adverse side effects is expected to restrain the growth. Also, changing lifestyle such as consumption of tobacco, an increase in the use of alcohol, and other associated products, growing stress levels, and the expanding population are expected to spur the market. Increasing disposable incomes coupled with expanding emphasis on aesthetic appearance are also likely to add to the demand for alopecia treatment worldwide.

Hair loss, also acknowledged as alopecia or baldness refers to a loss of hair from part of the head. The typical pattern of hair loss can vary from a small area to the entire body. Scarring or inflammation is not present. Hair loss in some people may cause psychological distress.

General types include female-pattern hair loss, male-pattern hair loss, alopecia areata, and a thinning of hair also known as telogen effluvium. The cause of male-pattern hair loss is a combination of male hormones and genetics, the purpose of female pattern hair loss is not clear, the use of alopecia areata is auto-immune, and the cause of telogen effluvium is mostly a psychological or physically stressful event.

The rising number of the introduction of new drugs, consumer disposable incomes, and the complementary initiatives taken by the relevant organizations namely, AHLA and NAAF, are the crucial factors for the North America region to account for the largest market share of 22.30% in 2018.

Key Coverage of the Report

Region and country wise statistics of Alopecia Market from the period 2016-2026. While 2016-2017 has been utilized as historical data, 2018 is considered the base year. 2019-2026 have been derived as forecasts.
Estimation of the market size along with historic and forecasted trend analysis.
Various Cure Types of Alopecia Market technique have been analyzed. Statistical analysis has been conducted on obtaining the individual share of these segments.
Regional up-coming Alopecia Market outlook.
Regional prevalence of the market has been mapped.
Demand and Supply GAP Analysis
Regional Competitors Pricing Strategy
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments.

Salient Trends of the Alopecia Market

The market is projected to grow at a CAGR of 1% in terms of value and reach USD 12.99 billion in 2026.
Based on disease type, the alopecia market is classified into androgenetic alopecia, alopecia areata (AA), and others. Androgenetic type led this market in 2018 with the largest revenue of USD 3.65 billion in 2018 and is expected to grow at a favorable rate over the forecast period.
Alopecia areata is an autoimmune skin disease identified by hair loss on the scalp, face, and other areas of the body. Alopecia areata is segmented into totalis, patchy, and universalis further.
The rising predominance of alopecia areata owing to autoimmune diseases such as diabetes, hyperthyroidism, and Down’s syndrome is expected to drive demand over the forecast period.
Increasing predominance coupled with rising awareness regarding aesthetic appeal and physical appearance is also assumed to drive market growth in the next few years.
Alopecia areata is expected to be the fastest-growing market with a CAGR of 5.2% during the forecast period.
Steroid injections may treat alopecia areata in the affected area, but these need to be continuously repeated to be effective. Hair loss is a common problem. The pattern of hair loss by age 50 affects about half of males and a quarter of females. About 1-2% of people develop alopecia areata at some point in time.
Male-Pattern Hair Loss (MPHL) or Androgenetic alopecia is associated with various medical conditions such as diabetes, coronary heart disease, obesity, prostate cancer, hypertension, and Polycystic Ovary Syndrome (PCOS).
Also, the availability of treatments such as oral treatments, licensed topical treatments involving the use of finasteride and minoxidil; and surgical procedures such as hair replacement and transplantation are expected to drive the market.
Laser treatments are also becoming common for non-invasive approach. Such non-invasive treatment approaches are also likely to drive the androgenetic segment.
The global Alopecia Market is growing at a rapid speed owing to the increase in stress and changed lifestyle.
The market can be classified into home care settings and dermatology clinics, based on application. Dermatology clinics account for the largest market share of 54.24% in 2018 and are anticipated to grow at a fruitful rate over the forecast period.
Dermatology clinics coupled with innovative technologies and prescription hair care products help many affected individuals fight their condition.
Consultation with dermatologists is regarded as the best option for the treatment, as they prescribe suitable medication or therapy for effective results. These factors are responsible for the high need for dermatology clinics for hair loss treatment.
On the other hand, treatment in home care settings is expected to grow at a rate of 5.1% during the forecast period.
Prescription medicine segment is anticipated to grow owing to increasing disposable income and quickly changing lifestyle. Finasteride and Corticosteroids are some of the majorly prescribed medications.
Based on the sales distribution, the market is segmented into prescription-based medications or treatment devices and Over the Counter (OTC).
Sale of prescription products account for the larger market share of 68.85% in 2018 and is estimated to reach USD 5.95 billion by 2026.
The OTC segment is expected to grow at a rate of 5.1% during the forecast period.
Increasing R&D efforts to improve treatments, FDA approvals obtained for certain products and strategic initiatives taken by the key players, are the primary competitive strategies paving the way for market expansion.
In April 2016, Johnson & Johnson announced the launch of a new global healthcare initiative to implement healthcare solutions, in Africa.
The developing prosperity of countries such as Indonesia, Taiwan, China, and India is inviting new international ventures in these countries thereby leading to the growth of various industries in the APAC region.

Companies considered and profiled in this market study

Cipla Inc., Johnson and Johnson AG, Transitions Hair Pty Ltd., Sun Pharmaceutical Industries Ltd., Merck & Co., Inc.,  Cirrus Hair Centers, Lexington International LLC,  Vita-Cos-Med Klett-Loch GmbH, Follica, Inc., and Capillus.

Market-O-Nomics

Rising demand for low-cost treatment, growing awareness regarding adverse effects of prescribed drugs, and the increasing availability of options are spurring the need for OTC products.
Moreover, a surge in the number of FDA-approved OTC products for hair loss treatments is additionally expanding their demand. Some of the FDA-approved OTC products for hair loss treatment are Oscar Blandi hair lift instant thickening and strengthening serum and Keranique hair regrowth system.
In 2018, the dominant gender segment for the alopecia market is women that accounts for the larger market share of 56.48%. The growing awareness amongst women about alopecia and the importance laid upon appearance by them are the key drivers of this segment.
Due to the predominance of a vast number of new entrants, established manufacturers, and suppliers in the market, the industry is extremely competitive.
Asia Pacific is forecasted to witness the fastest CAGR of 5.4% during the forecast period. A vast population suffering from alopecia and growing awareness about the available therapeutic options are the key growth drivers.
Economic development coupled with continually increasing per capita healthcare investment in emerging countries such as India, China, and Singapore is expected to create high growth opportunities.
Innovations and technological trends in treatment, evolving healthcare expenditures, and increased healthcare facilities are expected to drive the growth further.

Segments Covered in the report:

This report forecasts revenue growth at a global, regional & country level, and provides an analysis on the industry trends in each of the sub-segments from 2018 to 2026.

For the purpose of this study, Reports and Data have segmented the global Alopecia Market on the basis of Disease, Gender, application, Sales distribution and region:

Disease Outlook (Revenue, USD Million; 2016-2026)

Alopecia Areata
Androgenetic Alopecia
Others

Sales distribution Outlook (Revenue, USD Million; 2016-2026)

Prescriptions
OTC

Application Outlook (Revenue, USD Million; 2016-2026)

Homecare Settings
Dermatology Clinics

Gender Outlook (Revenue, USD Million; 2016-2026)

Female
Male

Regional Outlook (Revenue, USD Million; 2016-2026)

North America
U.S.
Europe
Germany
UK
Asia Pacific
China
India
Southeast Asia
Latin America
Brazil
Middle East & Africa

Source

Previous Posts

Alopecia Treatment Market

Alopecia Drugs Market Summary

Alopecia Drugs Market Summary, Trends, Sizing Analysis and Forecast To 2025

According to the latest research report on “Global Alopecia Drugs  Market” report provides information related to market size, production, CAGR, gross margin, growth rate, emerging trends, price, and other important factors.

Focusing on the key momentum and restraining factors in this market, the report also provides a complete study of future trends and developments in the market.

The Alopecia Drugs report contains all the details of the expected market dynamics and new market opportunities due to the COVID-19 outbreak. Stratagem Market Insights tried to cover all the market analysis of annual economic growth in the latest report on the Alopecia Drugs market.

According to analysts, the growth of the Alopecia Drugs market will have a positive impact on the global platform and will witness gradual growth over the next few years. This report study incorporates all the market growth and restraining factors along with the important trends mentioned between 2020 and 2025.

Market segmentation:

The Alopecia Drugs market has been segmented into a variety of essential industries including applications, types, and regions. In the report, each market segment is studied extensively, taking into account market acceptance, value, demand, and growth prospects. Segmentation analysis allows customers to customize their marketing approach to make better orders for each segment and identify the most potential customers.

Market Segmentation by Application:

Men and Women

Market Segmentation by Product:

Oral
Topical and Injectable

Competitive Landscape

This section of the report identifies various major manufacturers in the market. It helps readers understand the strategies and collaborations players are focusing on fighting competition in the marketplace. The comprehensive report gives a microscopic view of the market.

The reader can identify the manufacturer’s footprint by knowing about the manufacturer’s global revenue, the manufacturer’s global price, and the manufacturer’s production during the forecast period.

The major manufacturers covered in this report:

Helix BioMedix
Merck
GlaxoSmithKline
The Himalaya Drug Company
Johnson & Johnson
Dr. Reddy’s Laboratories Ltd
AndroScience
Bayer HealthCare
Aqua Pharmaceuticals and Cipla Inc

Regional Insights of Alopecia Drugs  Market:

In terms of geography, this research report covers almost all major regions around the world such as North America, Europe, South America, Middle East, Africa, and the Asia Pacific. Europe and North America are expected to increase over the next few years.

Alopecia Drugs markets in the Asia-Pacific region are expected to experience significant growth during the forecast period. Advanced technology and innovation are the most important characteristics of North America and the main reason why the United States dominates the world market. The Alopecia Drugs market in South America is also expected to expand in the near future.

Years considered for this report:

Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025

Important Facts about Alopecia Drugs  Market Report:

Market share valuations of the segments on the country and global level
Share analysis of the major market players
Opportunities for new market entrants
Market forecast for a minimum of six years for all the segments, sub-segments in various countries and regions
Market Trends (drivers, restraints, opportunities, threats, challenges, investment opportunities, and approvals)
Strategic endorsements in key business segments on the basis of market valuations
Competitive scenario mapping the key development patterns.
Company profiling with comprehensive strategies, financial details, and recent progressions.
Supply chain trends representing the latest technological advancements.

Questions Answered by the Report:

What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving the Global Alopecia Drugs  Market?
What are the challenges to market growth?
Who are the key vendors in space?
What are the key market trends impacting the growth of the Global Alopecia Drugs  Market?
What are the key outcomes of the five forces analysis of the Global Alopecia Drugs  Market?

Alopecia Drugs Market Summary, Trends, Sizing Analysis and Forecast To 2025

Source

Previous Posts

Alopecia Treatment Market

Global Androgenic Alopecia Drug Market

Global Androgenic Alopecia Drug Market Insights and Forecast to 2026

Report Description

Androgenic Alopecia Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Androgenic Alopecia Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Androgenic Alopecia Drug market is segmented into

RK-023
Refagro
RCH-01
SM-04554
HYG-440
Others

Segment by Application, the Androgenic Alopecia Drug market is segmented into

Clinic
Hospital
Home Use

Regional and Country-level Analysis

The Androgenic Alopecia Drug market is analysed and market size information is provided by regions (countries).

The key regions covered in the Androgenic Alopecia Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes a country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Androgenic Alopecia Drug Market Share Analysis

Androgenic Alopecia Drug market competitive landscape provides details and data information by players. The report offers a comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020.

Details included are company description, major business, company total revenue and the sales, revenue generated in Androgenic Alopecia Drug business, the date to enter into the Androgenic Alopecia Drug market, Androgenic Alopecia Drug product introduction, recent developments, etc.

The major vendors covered:

Allergan, Inc.
Histogen, Inc.
R-Tech Ueno, Ltd.
Hygeia Therapeutics, Inc.
SWITCH Biotech LLC
Polichem S.A.
Kasiak Research Pvt. Ltd.

Global Androgenic Alopecia Drug Market Insights and Forecast to 2026

Source

Recent Posts

Alopecia Treatment Market

Global Alopecia Treatment

Global Alopecia Treatment (Hair Loss) Market– Industry Trends and Forecast to 2026

Global Alopecia Treatment (Hair Loss) Market, By Disease Type (Androgenic Alopecia, Alopecia Areata, Ciatricial Alopecia, Traction Alopecia, Alopecia Totalis), Drug Type (Minoxidil, Finasteride, Cyclosporine and Others), Gender (Male, Female), Route of Administration (Oral, Topical, Injectable), Distribution Channel (Hospital, Retail Pharmacies, Online Pharmacies), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)–Industry Trends & Forecast to 2026

Market Analysis: Global Alopecia Treatment (Hair Loss) Market

The Global Alopecia Treatment (Hair Loss) Market is expected to rise from its initial estimated value of USD 8.21 billion in 2018 to an estimated value of USD 12.40 billion by 2026 registering a CAGR of 5.3% in the forecast period of 2019-2026. This rise in the market can be attributed to the rising geriatric population along with high demand for surgical hair transplant and changing lifestyle.

Market Definition: Global Alopecia Treatment (Hair Loss) Market

Alopecia areata is a medical condition which is a type of alopecia which attacks the hair follicles causes the breakage or fall of hair leading to complete baldness. The patient suffering from alopecia areata, their scalp becomes patchy, diffused and confluent pattern leading the hair fall initially and later spread over the entire scalp termed as alopecia totalis or entire epidermis.

Alopecia areata is an autoimmune hair loss on the scalp or on the body and commonly it shows a form of solitary and multiple patches of alopecia.

Market Drivers:

  • The rising geriatric population along with high demand for surgical hair transplant will boost the market
  • Changing lifestyle along with an increase in stress level among the working-class population can fuel the growth of the market

Market Restraints:

  • High cost of alopecia treatment (hair loss) is acting as a major restraint for the market
  • Side effects/allergic reactions by treatment also acting as a major market restraint.

Segmentation: Global Alopecia Treatment (Hair Loss) Market

  • By Disease Type
    • Androgenic Alopecia
    • Alopecia Areata
    • Ciatricial Alopecia
    • Traction Alopecia
    • Alopecia Totalis
  • By Drug Type
    • Minoxidil
    • Finasteride
    • Cyclosporine
    • Others
  • By Gender
    • Male
    • Female
  • By Route of Administration
  • Oral
    • Topical
    • Injectable
  • By Distribution Channel
    • Hospital
    • Retail Pharmacies
    • Online Pharmacies
  • By Geography
    • North America
      • US
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
      • Russia
      • Turkey
      • Belgium
      • Netherlands
      • Switzerland
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • South Korea
      • India
      • Australia
      • Singapore
      • Malaysia
      • Indonesia
      • Thailand
      • Philippines
      • Rest of Asia-Pacific
    • Middle East and Africa
      • South Africa
      • Egypt
      • Saudi Arabia
      • United Arab Emirates
      • Israel
      • Rest of Middle East and Africa

Key Developments in the Market:

  • In January 2018, Concert Pharmaceuticals, Inc. announced U.S. FDA granted Fast Track designation for CTP-543, a novel, oral Janus kinase (JAK) inhibitor for the treatment of moderate-to-severe alopecia areata, a disease which attacks the hair follicles, leading to hair loss.
  • In May 2018, Histogen, Inc (U.S.) announced that received approval to Investigational New Drug (IND) application from the US Food and Drug Administration (FDA) to study its lead product in female diffuse hair loss.
  • In March 2017, Perrigo Perrigo Company PLC (U.S.) announced the launch of over-the-counter Women’s Rogaine, which helps to regrow hair on top of the scalp.

Competitive Analysis: Global Alopecia Treatment (Hair Loss) Market

The global alopecia treatment (hair loss) market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of alopecia treatment (hair loss) market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Key Market Competitors: Global Alopecia Treatment (Hair Loss) Market

Few of the major market competitors currently working in the alopecia treatment (hair loss) market are Cipla, Viviscal, Dr. Reddy’s Laboratories Ltd., Regaine, Merck & Co., Inc, Ranbaxy Laboratories Ltd, Phyto – Alès Groupe, Kirkland Signature, Vitabiotics, Nanogen, Alpecin – Dr. Kurt Wolff GmbH & Co. KG, Rogaine – Johnson and Johnson, Histogen, Inc., Aclaris Therapeutics, Inc., Concert Pharmaceuticals, Inc., HCell Inc., GlaxoSmithKline plc., Perrigo Company PLC. and Daiichi Sankyo, Inc.

Research Methodology: Global Alopecia Treatment (Hair Loss) Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report.

Primary Respondents:

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report:

  • Current and future of global alopecia treatment (hair loss) market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at the country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Global Alopecia Treatment (Hair Loss) Market– Industry Trends and Forecast to 2026

Source

Recent Posts

Alopecia Treatment Market

Alopecia Treatment Market

Alopecia (Hair Loss)Treatment Market Analysis by Region Analysis and Business Development, By 2026

Global  Alopecia (Hair Loss)Treatment market Size study report with COVID-19 effect is considered to be an extremely knowledgeable and in-depth evaluation of the present industrial conditions along with the overall size of the  Alopecia (Hair Loss)Treatment industry, estimated from 2020 to 2026.

The research report also provides a detailed overview of leading industry initiatives, potential market share and business-oriented planning, etc.

The study discusses favourable factors related to current industry conditions, levels of growth of the  Alopecia (Hair Loss)Treatment industry, demands, differentiable business-oriented approaches used by the manufacturers of the  Alopecia (Hair Loss)Treatment industry in brief about distinct tactics and futuristic prospects.

The research report on  Alopecia (Hair Loss)Treatment market provides a comparative study of the historical data with the changing market scenario to reveal the future roadmap of the industry. It offers detailed insights pertaining to the growth markers, challenges and opportunities residing in this industry vertical.

A magnified view of the regional landscape and competitive terrain of this business sphere is also encompassed in the document. In addition, the report reevaluates the market behaviour considering the impact of COVID-19 on the business landscape.

Alopecia (Hair Loss)Treatment  market rundown:

As per the report, North America, Asia-Pacific, Europe, Latin America, Middle East & Africa and Rest of MEA are the key regional contributors of the  Alopecia (Hair Loss)Treatment market.
Information underpinning the market share accounted by each regional market along with their consumption graph and growth rate over the forecast period are included in the report.
Growth opportunities with respect to several economic indicators are listed for providing actionable intelligence to industry partakers.

Competitive outlook of the  Alopecia (Hair Loss)Treatment  market:

Company profiles, inclusive of Cipla, Dr Reddya??s Laboratories,    Regaine,    Merck,    Ranbaxy Laboratories,    Vitabiotics,    Nanogen,    Alpecin and    Johnson and Johnson are listed in the report.
A systematic representation of the product offerings of top contenders, together with their specifications and top applications is given.

An overview of regional terrain:

The manufacturing base of leading players, their operational regions and market share are elucidated.

Pricing models followed by each company and their returns are also recorded.

Updates regarding market concentration rate, key development trends, mergers & acquisitions, and new entrants are documented as well.

Other important takeaways from the  Alopecia (Hair Loss)Treatment  market report:

The product range of the  Alopecia (Hair Loss)Treatment market comprises Vitamins and Supplements,    Shampoos and Conditioners and    Others.
Consumption share, market share, sales price, and remuneration accrued by each product type is encompassed in the report.
The application scope of the various products is categorized into Men,    Women and    Children.
Predictions regarding the consumption value & volume and industry share held by each application are validated.
A comprehensive study of the industry supply chain emphasizing on the distribution channels, producers, distributors, and downstream buyers is furnished in the report.

The report answers important questions that companies may have when operating in the global  Alopecia (Hair Loss)Treatment market. Some of the questions are given below:

What will be the size of the global  Alopecia (Hair Loss)Treatment market in 2026?

What is the current CAGR of the global  Alopecia (Hair Loss)Treatment market?

Which product is expected to show the highest market growth?

Which are the top players currently operating in the global  Alopecia (Hair Loss)Treatment market?

Which application is projected to gain a lion’s share of the global  Alopecia (Hair Loss)Treatment market?

Will there be any changes in market competition during the forecast period?

Which region is foretold to create the most number of opportunities in the global  Alopecia (Hair Loss)Treatment market?

Alopecia (Hair Loss)Treatment Market Analysis by Region Analysis and Business Development, By 2026

Source

Recent Posts